COMP <GO>
STE vs ZBH // ENTERPRISE SCALE & MARKET CAP
STERIS plc (Ireland) (NYSE) VS. Zimmer Biomet Holdings Inc. (NYSE) • 15-METRIC TALLY: STE 11
— ZBH 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: STE
LAST: $227.12 (-2.16%) • MKT CAP: $22.63B
market-cap
$22.63B
LAST: $94.52 (-3.03%) • MKT CAP: $18.59B
market-cap
$18.59B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. ZBH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | ZBH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 69.70% | -25.50 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 4.60% | +5.50 | STE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 19.3x | -2.30 | STE | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 7.92% | -3.62 | ZBH | /fcf-yield <GO> |
| Operating Margin | 18.60% | 13.30% | +5.30 | STE | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 8.60% | +4.60 | STE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 7.20% | +1.50 | STE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 1.02% | +0.05 | STE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 2.42 | +2.98 | STE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 57.0 | +5.40 | STE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.02 | +0.06 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 24.6x | +2.30 | ZBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $22.63B | $18.59B | $4.04B | STE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | ZBH REV | STE GROSS % | ZBH GROSS % | STE FCF | ZBH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $8.23B | 44.2% | 69.7% | $972.4M | $1.47B |
| FY 2024 | $5.46B | $7.68B | — | 71.5% | $778.0M | $1.30B |
| FY 2023 | $5.14B | $7.39B | — | — | $742.1M | $1.25B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
ZBH // BETA 1.02